<\/p>\n
Alman mahremiyet yasas\u0131 kapsam\u0131nda ad\u0131n\u0131n gizli kalmas\u0131 hakk\u0131n\u0131 kullanan orta ya\u015fl\u0131 bir sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131 ad\u0131na hukuk firmas\u0131 Rogert & Ulbrich taraf\u0131ndan a\u00e7\u0131lan dava, yar\u0131n Hamburg B\u00f6lge Mahkemesi’nde ba\u015flayacak.<\/p>\n
S\u00f6z konusu sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131, a\u015f\u0131 olduktan sonra ortaya \u00e7\u0131kt\u0131\u011f\u0131n\u0131 s\u00f6yledi\u011fi kalp ritmi bozuklu\u011fu, v\u00fccudunun \u00fcst k\u0131sm\u0131nda a\u011fr\u0131, kol ve bacaklarda \u015fi\u015flik, yorgunluk, uyku bozuklu\u011fu ve beyin sisi gibi semptomlar\u0131n neden oldu\u011fu bedensel zarar i\u00e7in 150 bin avro tazminat talep etti. Davac\u0131, ayr\u0131ca belirlenmemi\u015f maddi zarar i\u00e7in de tazminat talebinde bulundu.<\/p>\n
S\u00f6z konusu dava, iki hukuk firmas\u0131 taraf\u0131ndan takip edilen milyonlarca avro tazminat talebinden biri olmas\u0131yla dikkati \u00e7ekiyor. Davalar\u0131 a\u00e7an di\u011fer hukuk firmas\u0131 Mainz merkezli Casar-Preller olurken, Rogert & Ulbrich, Kovid-19 a\u015f\u0131lar\u0131n\u0131n iddia edilen yan etkileri nedeniyle tazminat talep eden m\u00fc\u015fteriler i\u00e7in yakla\u015f\u0131k 250 dava a\u00e7t\u0131\u011f\u0131n\u0131, Caesar-Preller de 100 davay\u0131 temsil etti\u011fini duyurdu.<\/p>\n
2 hukuk firmas\u0131, daha \u00f6nce Alman otomobil \u00fcreticisi Volkswagen’in dizel emisyon skandal\u0131 nedeniyle t\u00fcketicilere tazminat \u00f6denmesini sa\u011flam\u0131\u015ft\u0131.<\/p>\n
Almanya’da uygulanan 224 milyon a\u015f\u0131 dozunun yakla\u015f\u0131k d\u00f6rtte \u00fc\u00e7\u00fc BioNTech taraf\u0131ndan \u00fcretilirken, tazminat taleplerinin b\u00fcy\u00fck \u00e7o\u011funlu\u011funun a\u015f\u0131larda mRNA teknolojisinin kullan\u0131m\u0131na \u00f6nc\u00fcl\u00fck eden BioNTech’e kar\u015f\u0131 a\u00e7\u0131ld\u0131\u011f\u0131 belirtildi.<\/p>\n
Almanya’daki davalar, BioNTech’in Kovid-19 salg\u0131n\u0131ndan bu yana d\u00fcnya \u00e7ap\u0131nda kar\u015f\u0131la\u015ft\u0131\u011f\u0131 en b\u00fcy\u00fck tazminat talebini temsil ediyor.<\/p>\n
\u0130talya’da da Kovid-19 a\u015f\u0131lar\u0131n\u0131n yan etkileri iddias\u0131yla benzer davalar a\u00e7\u0131lm\u0131\u015ft\u0131.<\/p>\n
Pfizer ile geli\u015ftirdi\u011fi a\u015f\u0131y\u0131 Almanya’da pazarlayan BioNTech’ten yap\u0131lan a\u00e7\u0131klamada, dikkatli bir incelemeden sonra s\u00f6z konusu davalar\u0131n “dayanaks\u0131z” oldu\u011fu ve reddedilece\u011finden emin olundu\u011fu belirtildi.<\/p>\n
A\u00e7\u0131klamada, en az 64 milyonu Almanya’da olmak \u00fczere, d\u00fcnya \u00e7ap\u0131nda yakla\u015f\u0131k 1,5 milyar insana s\u00f6z konusu a\u015f\u0131n\u0131n uyguland\u0131\u011f\u0131 ve bug\u00fcne kadar ilgili \u00fcr\u00fcn bilgilerinde zaten listelenenler d\u0131\u015f\u0131nda potansiyel yan etkiler tespit edilmedi\u011fi kaydedildi.<\/p>\n
Davac\u0131n\u0131n BioNTech aleyhine a\u00e7t\u0131\u011f\u0131 davay\u0131 kazanmas\u0131 halinde yasal masraflar\u0131 veya tazminat\u0131 kimin \u00f6deyece\u011finin belli olmamas\u0131 dikkati \u00e7ekiyor.<\/p>\n
Avrupa Birli\u011fi (AB) yasal kalkan\u0131n\u0131n, AB h\u00fck\u00fcmetlerini maliyetlerin bir k\u0131sm\u0131n\u0131 \u00fcstlenmeye zorlayabilece\u011fi belirtiliyor.<\/p>\n
AB’nin ila\u00e7 d\u00fczenleyicisi Avrupa \u0130la\u00e7 Ajans\u0131 (EMA), 6 Haziran’da yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, ABD, \u0130ngiltere ve Almanya gibi Bat\u0131l\u0131 \u00fclkelerde yayg\u0131n olarak kullan\u0131lan BioNTech’in Comirnaty a\u015f\u0131s\u0131n\u0131n kullan\u0131m\u0131n\u0131n g\u00fcvenli oldu\u011funu aktararak, d\u00fcnyan\u0131n bir\u00e7ok yerinde hakim konuma gelen Omicron varyant\u0131n\u0131n alt grubu XBB’ye g\u00f6re a\u015f\u0131lar\u0131n g\u00fcncellenmesi tavsiyesinde bulundu.<\/p>\n